NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/08/2020
Voltar para busca
Dado oficial do USPTO
EMBOZENE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
85
Atualização mais recente
31/03/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
10
Data de depósito
09/07/2004
Data de registro
13/07/2010
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/08/2020
Última transação
31/03/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
29/12/2008
Primeiro uso no comércio
29/12/2008
Código do desenho
4
Tipo de titular
11
Localização do titular
89077 ULM, DE
Examinador
JACKSON, STEVEN
Unidade examinadora
L70
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
Polyzenix GmbH
BOSTON SCIENTIFIC LIMITED
CELONOVA BIOSCIENCES, INC.
CELONOVA BIOSCIENCES GERMANY GMBH
VARIAN MEDICAL SYSTEMS, INC.
Imed Devices, Inc.
Representantes
Kelly P. McCarthy Sideman & Bancroft LLP
Classificação técnica
Classes Nice
Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 10
Coated medical devices for embolizationembolic microspheres for embolization and syringes; Coated medical devices for embolizationembolic microspheres for embolization in the form of particles; Coated medical devices for embolizationembolic devices in the form of particles to slow or block blood flow for mediating devascularizations; Coated medical devices for embolizationembolic devices in the form of particles to block blood flow throughout the vasculature system of mammals; Coated medical devices for embolizationembolic devices in the form of particles to treat hemorrhagesarteriovenous malformationshemangioendotheliomacerebral aneurysmsmuscle hypertrophyhypertrophic cardiomyopathygastrointestinal bleedingtraumaepistaxisbone cystsbone metastasesvertebral metastasesvaricocelescongenital hemangiomaartiovenous fistulaevena cavavascular anomaliespriapismprostatic hematuriahemoptysishemorrhagic cystitispost-partum hemorrhage; Coated medical devices for embolizationembolic devices in the form of particles to prevent or reduce blood flow through any tissue or organ of interest in order to reduce the growths of malignant cellstumorslesionshepatocellular carcinomafibroids; Coated medical devices for embolizationembolic devices in the form of particles to treat vascular conditions
Publicações
Histórico de despachos e eventos da marca no USPTO.
85 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
05/08/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/08/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/08/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
05/06/2020
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/02/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/11/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/11/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
13/07/2019
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
20/08/2016
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
20/08/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
20/08/2016
E815
TEAS SECTION 8 & 15 RECEIVED
08/06/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27/01/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27/01/2016
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
27/01/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
13/07/2010
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
08/06/2010
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
07/06/2010
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/06/2010
XAEC
EXAMINER'S AMENDMENT ENTERED
04/06/2010
CNEA
EXAMINERS AMENDMENT MAILED
03/06/2010
SNEA
SU-EXAMINER'S AMENDMENT WRITTEN
03/06/2010
CNFR
FINAL REFUSAL MAILED
07/12/2009
CNFR
SU - FINAL REFUSAL - WRITTEN
04/12/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/11/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/11/2009
ALIE
ASSIGNED TO LIE
19/11/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/11/2009
CNRT
NON-FINAL ACTION MAILED
16/07/2009
CNRT
SU - NON-FINAL ACTION - WRITTEN
16/07/2009
SUPC
STATEMENT OF USE PROCESSING COMPLETE
15/07/2009
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
14/07/2009
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
24/06/2009
IUAF
USE AMENDMENT FILED
19/06/2009
EISU
TEAS STATEMENT OF USE RECEIVED
19/06/2009
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/06/2009
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/06/2009
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
12/05/2009
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
12/05/2009
EX5G
SOU EXTENSION 5 GRANTED
09/12/2008
EXT5
SOU EXTENSION 5 FILED
09/12/2008
EEXT
SOU TEAS EXTENSION RECEIVED
09/12/2008
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/12/2008
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/12/2008
EX4G
SOU EXTENSION 4 GRANTED
01/07/2008
EXT4
SOU EXTENSION 4 FILED
19/06/2008
EEXT
SOU TEAS EXTENSION RECEIVED
19/06/2008
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
14/05/2008
EX3G
SOU EXTENSION 3 GRANTED
11/01/2008
EXT3
SOU EXTENSION 3 FILED
17/12/2007
EEXT
SOU TEAS EXTENSION RECEIVED
17/12/2007
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/11/2007
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/11/2007
EX2G
SOU EXTENSION 2 GRANTED
30/08/2007
EXT2
SOU EXTENSION 2 FILED
11/06/2007
EEXT
SOU TEAS EXTENSION RECEIVED
11/06/2007
EX1G
SOU EXTENSION 1 GRANTED
07/12/2006
EXT1
SOU EXTENSION 1 FILED
07/12/2006
EEXT
SOU TEAS EXTENSION RECEIVED
07/12/2006
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
20/06/2006
PUBO
PUBLISHED FOR OPPOSITION
28/03/2006
NPUB
NOTICE OF PUBLICATION
08/03/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
14/02/2006
ALIE
ASSIGNED TO LIE
10/02/2006
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/02/2006
XAEC
EXAMINER'S AMENDMENT ENTERED
28/01/2006
GNEA
EXAMINERS AMENDMENT E-MAILED
27/01/2006
CNEA
EXAMINERS AMENDMENT -WRITTEN
27/01/2006
GNFR
FINAL REFUSAL E-MAILED
29/12/2005
CNFR
FINAL REFUSAL WRITTEN
29/12/2005
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/12/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/11/2005
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/11/2005
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
25/10/2005
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
25/10/2005
CNRT
NON-FINAL ACTION MAILED
14/06/2005
CNRT
NON-FINAL ACTION WRITTEN
14/06/2005
ACEC
AMENDMENT FROM APPLICANT ENTERED
06/05/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/04/2005
PAPER RECEIVED
18/04/2005
CNRT
NON-FINAL ACTION MAILED
14/02/2005
CNRT
NON-FINAL ACTION WRITTEN
12/02/2005
DOCK
ASSIGNED TO EXAMINER
12/02/2005
NWAP
NEW APPLICATION ENTERED
21/07/2004
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EMBOZENE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.